Category: PASC

Sleep Disturbances Are Highly Prevalent Among People With Long COVID

Posted on | Posted on John Murphy | Leave a Comment on Sleep Disturbances Are Highly Prevalent Among People With Long COVID

Black race, COVID-19 hospitalization and mood symptoms confer increased risk, study finds Moderate to severe sleep disturbances are highly prevalent among patients with post-acute sequelae of COVID-19 (PASC), or “long…[...]

Inflammatory profiles are associated with long COVID up to 6 months after COVID-19 onset

Posted on | Posted on John Murphy | Leave a Comment on Inflammatory profiles are associated with long COVID up to 6 months after COVID-19 onset

Elke Wynberg , Alvin X. Han , Hugo D. G. van Willigen , et. al. on behalf of the RECoVERED Study Group  https://doi.org/10.1371/journal.pone.0304990 Background After initial COVID-19, immune dysregulation may persist and drive…[...]

Postacute Sequelae of SARS-CoV-2 Infection in the Pre-Delta, Delta, and Omicron Eras

Posted on | Posted on John Murphy | Leave a Comment on Postacute Sequelae of SARS-CoV-2 Infection in the Pre-Delta, Delta, and Omicron Eras

Authors: Yan Xie, Ph.D. https://orcid.org/0000-0002-2457-9382, Taeyoung Choi, M.S., and Ziyad Al-Aly, M.D. https://orcid.org/0000-0002-2600-0434, N Engl J Med 2024;391:515-525, DOI: 10.1056/NEJMoa2403211, VOL. 391 NO. 6 Abstract Background Postacute sequelae of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection (PASC) can affect many organ systems. However, temporal…[...]

What Do We Know About Long COVID?

Posted on | Posted on John Murphy | Leave a Comment on What Do We Know About Long COVID?

COVID-19 is a respiratory disease caused by an infection with the SARS-CoV-2 virus. The disease causes symptoms such as fever, cough, and shortness of breath. Symptoms can feel much like…[...]

Persistence of SARS CoV-2 S1 Protein in CD16+ Monocytes in Post-Acute Sequelae of COVID-19 (PASC) up to 15 Months Post-Infection

Posted on | Posted on John Murphy | Leave a Comment on Persistence of SARS CoV-2 S1 Protein in CD16+ Monocytes in Post-Acute Sequelae of COVID-19 (PASC) up to 15 Months Post-Infection

Authors: Bruce K. Patterson, 1 , * Edgar B. Francisco, 1 Ram Yogendra, 2 et. al., Front Immunol. 2021; 12: 746021.Published online 2022 Jan 10. doi: 10.3389/fimmu.2021. 746021PMCID: PMC8784688PMID: 35082777 Abstract The recent COVID-19 pandemic is a treatment challenge in the acute…[...]

POST-ACUTE SEQUELAE OF COVID-19: CHARACTERIZATION, COMORBIDITIES, AND BIOMARKERS IN A DIVERSE COHORT

Posted on | Posted on John Murphy | Leave a Comment on POST-ACUTE SEQUELAE OF COVID-19: CHARACTERIZATION, COMORBIDITIES, AND BIOMARKERS IN A DIVERSE COHORT

Emily Struttmann, Anish Shah, Matthew Moreida, et. al. doi: https://doi.org/10.1101/2024.06.20.24308901 Abstract Introduction Post-acute sequelae of COVID-19 (PASC) is causing a silent pandemic in the U.S. Gulf South, a part of flyover U.S. where patients are quietly withdrawing…[...]

Sleep and Long COVID—A Review and Exploration of Sleep Disturbances in Post Acute Sequelae of SARS-COV-2 (PASC) and Therapeutic Possibilities

Posted on | Posted on John Murphy | Leave a Comment on Sleep and Long COVID—A Review and Exploration of Sleep Disturbances in Post Acute Sequelae of SARS-COV-2 (PASC) and Therapeutic Possibilities

Volume 10, pages 169–180, (2024), Elliott K Lee & R. Robert Auger  Abstract Purpose of Review Post Acute Sequelae of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-COV-2), also known as PASC, and frequently referred to…[...]

Pathophysiological, immunological, and inflammatory features of long COVID

Posted on | Posted on John Murphy | Leave a Comment on Pathophysiological, immunological, and inflammatory features of long COVID

Karen Bohmwald1,2†Benjamín Diethelm-Varela1†Linmar Rodríguez-Guilarte1 , et. al., Front. Immunol., 27 February 2024, Sec. Viral Immunology, Volume 15 - 2024 | https://doi.org/10.3389/fimmu.2024.1341600 The COVID-19 pandemic continues to cause severe global disruption, resulting…[...]